Posted by on Apr 10, 2016 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study evaluated the safety and effectiveness of silodosin (Rapaflo) in treating urinary symptoms among men with benign prostatic hyperplasia (BPH). Researchers concluded that silodosin is well-tolerated and significantly improves a range of urinary symptoms in most men. Some background Drugs that are commonly prescribed for...

Read More